European Psychiatry
October 23, 2023
O. Martin-Santiago, G. Guerra-Valera, C. Alario-Ruiz et al.
Introduction The presence of perceptual disturbances and psychotic symptoms associated with substance abuse are widely known. While the abuse of substances is becoming more widespread, there is a general perception that their use entails fewer risks. 25I-NBOMe is a recently introduced hallucinogenic drug producing visual hallucinations and euphoria. Although people consume it like LSD, its...
International Journal of Education and Literacy Studies
October 20, 2023
Ezgi Özeke-Kocabaş, Bengisu Koyuncu
1 citation
This preliminary study aims to address situations such as high anxiety, stress, inability to focus, and physical burnout experienced by students in the exams made during the transition to a higher education process in the educational system. It also aims to contribute to the development of students’ academic and social-emotional skills, in other words emotional literacy through mindfulness...
The Plant Journal
October 20, 2023
Gwendolyn K. Kirschner
2 citations
The small, globular cactus peyote (Lophophora williamsii) is known for its ability to produce mescaline, a phenethylamine protoalkaloid (Figure 1). Consuming the mescaline-containing dried tops or “buttons” of peyote has a psychedelic effect that has been used in religious ceremonies by Indigenous communities for over 5800 years (Cassels & Sáez-Briones, 2018). Nowadays, psychedelic drugs are...
Canadian Liver Journal
October 19, 2023
Makayla Watt, Ashley Hyde, John C. Spence et al.
9 citations
Background: Persons with primary biliary cholangitis (PBC) experience significantly higher rates of mental distress and impaired health related quality of life (HrQoL) than the general population. Given limited evidence, but a high need, our primary aim was to assess feasibility and acceptability of a 12-week, online, mind–body wellness program in people with PBC. Methods: This was a...
Jurnal Pengabdian Perawat
October 19, 2023
Marsela Riska Raswandaru, Rosiana Eva Rayanti, Angreit Angel Priskila Rompas et al.
Terapi mindfulness merupakan terapi yang melibatkan peserta untuk mengamati pemikiran batin atau perasaan secara sadar dengan membawa pengalaman ke kondisi peserta saat ini dengan penuh rasa keterbukaan dan penerimaan terhadap pengalaman hidupnya. Terapi ini dapat memberikan pemahaman lebih pada peserta terkait pemikiran dan emosinya tanpa memberikan penghakiman. Tujuan pengabdian masyarakat...
Mindfulness
October 19, 2023
María Fernanda López-Ramón, Verónica Moreno Campos, Yurena Alonso-Esteban et al.
10 citations
Abstract Objectives The COVID-19 pandemic has caused high mortality rates worldwide, as well as consequent psychological and physical stress. The present study aimed to review the main existing scientific research studies conducted since the onset of the COVID-19 that have used mindfulness-based interventions (MBIs) as tools for emotional regulation, aiming to improve individuals’ ability to...
ACS Medicinal Chemistry Letters
October 19, 2023
Robert B. Kargbo
2 citations
Addressing the significant challenges of treating depression, anxiety, and substance abuse, this Patent Highlight explores the development of innovative small-molecule heterocyclic compounds as Gq-biased agonists of the 5-HT2A receptor. Unlike traditional treatments, these compounds selectively activate 5-HT2A-mediated Gq signaling, excluding related receptors like 5-HT2B and 5-HT2C. This...
Cultura y Droga
October 19, 2023
Laura Duque
Este artículo de reflexión sobre microdosificación con psilocibina se hizo con base en estudios observacionales, ensayos clínicos, una revisión sistemática y un estudio sociológico. La búsqueda se hizo en Pubmed usando los descriptores “psilocybin” y “microdosing”. Se tomaron artículos desde 2019 hasta enero de 2023, en inglés, enfocados en la microdosificación con psilocibina y principalmente...
Frontiers in Psychiatry
October 19, 2023
Brian S. Barnett, Anahita Bassir Nia, Nathan Sackett et al.
1 citation
Disclosures of Financial or Other Potential Conflicts of Interest: Dr. Barnett holds stock options in CB Therapeutics. He also serves on advisory boards for CB Therapeutics and Compass Pathways. He receives monetary compensation from DynaMed Plus (EBSCO Industries, Inc.) for editorial work and from Janssen Pharmaceuticals for consulting services. Dr. Barnett has received research funding from...
JMIR Formative Research
October 17, 2023
Nathan J. Dreesmann, D. Buchanan, H. Tang et al.
Background Effective symptom management is crucial to enhancing the quality of life for individuals with chronic diseases. Health care has changed markedly over the past decade as immersive, stand-alone, and wearable technologies including virtual reality have become available. One chronic pain population that could benefit from such an intervention is individuals with rheumatoid arthritis...